Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rocio K Finol-Urdaneta

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
The Journal of General Physiology|June 28, 2006
Molecular and Functional Differences between Heart mKv1.7 Channel IsoformsRocio K Finol-Urdaneta, Nina Strüver, Heinrich Terlau
Methods in Molecular Biology (Clifton, N.J.)|May 4, 2023
Calcium Imaging of Non-adherent CellsLydia J Bye, Rocio K Finol-Urdaneta, David J Adams
British Journal of Pharmacology|March 31, 2019
Analgesic transient receptor potential vanilloid-1-active compounds inhibit native and recombinant T-type calcium channelsJeffrey R McArthur, Rocio K Finol-Urdaneta, David J Adams
Neuropharmacology|May 24, 2017
Analgesic conopeptides targeting G protein-coupled receptors reduce excitability of sensory neuronsMahsa Sadeghi, Jeffrey R McArthur, Rocio K Finol-Urdaneta, et al.
British Journal of Pharmacology|October 2, 2021
Analgesic α-conotoxins modulate native and recombinant GIRK1/2 channels via activation of GABA<sub>B</sub> receptors and reduce neuroexcitabilityAnuja R Bony, Jeffrey R McArthur, Rocio K Finol-Urdaneta, et al.
The International Journal of Biochemistry & Cell Biology|February 8, 2023
Nicotinic acetylcholine receptors: Key targets for attenuating neurodegenerative diseasesLydia J Bye, Rocio K Finol-Urdaneta, Han-Shen Tae, et al.
Marine Drugs|July 28, 2023
Brevetoxin versus Brevenal Modulation of Human Nav1 ChannelsRocio K Finol-Urdaneta, Boris S Zhorov, Daniel G Baden, et al.
The Journal of Biological Chemistry|March 12, 2010
Biochemical characterization of kappaM-RIIIJ, a Kv1.2 channel blocker: evaluation of cardioprotective effects of kappaM-conotoxinsPing Chen, Andreas Dendorfer, Rocio K Finol-Urdaneta, et al.
Journal of Neurochemistry|November 14, 2025
Nicotinic Acetylcholine Receptor-Mediated Metabotropic Signalling in Human MicrogliaLydia J Bye, Marnie L Maddock, Rocio K Finol-Urdaneta, et al.
Elife|July 20, 2022
µ-Theraphotoxin Pn3a inhibition of Ca<sub>V</sub>3.3 channels reveals a novel isoform-selective drug binding siteJeffrey R McArthur, Jierong Wen, Andrew Hung, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
The Journal of General Physiology|June 28, 2006
Molecular and Functional Differences between Heart mKv1.7 Channel IsoformsRocio K Finol-Urdaneta, Nina Strüver, Heinrich Terlau
Methods in Molecular Biology (Clifton, N.J.)|May 4, 2023
Calcium Imaging of Non-adherent CellsLydia J Bye, Rocio K Finol-Urdaneta, David J Adams
British Journal of Pharmacology|March 31, 2019
Analgesic transient receptor potential vanilloid-1-active compounds inhibit native and recombinant T-type calcium channelsJeffrey R McArthur, Rocio K Finol-Urdaneta, David J Adams
Neuropharmacology|May 24, 2017
Analgesic conopeptides targeting G protein-coupled receptors reduce excitability of sensory neuronsMahsa Sadeghi, Jeffrey R McArthur, Rocio K Finol-Urdaneta, et al.
British Journal of Pharmacology|October 2, 2021
Analgesic α-conotoxins modulate native and recombinant GIRK1/2 channels via activation of GABA<sub>B</sub> receptors and reduce neuroexcitabilityAnuja R Bony, Jeffrey R McArthur, Rocio K Finol-Urdaneta, et al.
The International Journal of Biochemistry & Cell Biology|February 8, 2023
Nicotinic acetylcholine receptors: Key targets for attenuating neurodegenerative diseasesLydia J Bye, Rocio K Finol-Urdaneta, Han-Shen Tae, et al.
Marine Drugs|July 28, 2023
Brevetoxin versus Brevenal Modulation of Human Nav1 ChannelsRocio K Finol-Urdaneta, Boris S Zhorov, Daniel G Baden, et al.
The Journal of Biological Chemistry|March 12, 2010
Biochemical characterization of kappaM-RIIIJ, a Kv1.2 channel blocker: evaluation of cardioprotective effects of kappaM-conotoxinsPing Chen, Andreas Dendorfer, Rocio K Finol-Urdaneta, et al.
Journal of Neurochemistry|November 14, 2025
Nicotinic Acetylcholine Receptor-Mediated Metabotropic Signalling in Human MicrogliaLydia J Bye, Marnie L Maddock, Rocio K Finol-Urdaneta, et al.
Elife|July 20, 2022
µ-Theraphotoxin Pn3a inhibition of Ca<sub>V</sub>3.3 channels reveals a novel isoform-selective drug binding siteJeffrey R McArthur, Jierong Wen, Andrew Hung, et al.
Pageof 5